This is an aggregated industry headline. Read the full story at FierceBiotech →
KKR-backed Allyntra debuts to serve medtech industry as it announces new CEO
KKR, the global investment giant, has launched Allyntra as a new, precision-engineered solutions platform for the medtech industry while also announcing several senior management changes.
By FierceBiotech
· Jul 12, 2026
· via FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Bayer has addressed its need for a capital infusion under a deal to secure 3 billion euros ($3.4 billion) in e…
The WeekBriefing
The FDA has expanded the use of the Padcev-Keytruda combination in bladder cancer, intensifying competition fo…
The WeekFiercePharma ↗
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…